Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ASI Becomes Tergus Pharma | Contract Pharma
Breaking News

ASI Becomes Tergus Pharma

Expands services in dermatology development

Analytical Solutions, Inc. (ASI) is changing its name to Tergus Pharma, LLC, as part of the company’s new growth strategy in dermatology product development. According to a press statement, Tergus Pharma will provide “a broader range of topical drug development services from concept to commercialization, including product development strategy and design, target product profile development, formulation development, analytical method development and validation, preclinical and clinical supplies manufacturing, program management and logistics, scale-up and technology transfer, regulatory CMC consulting, disease model development, clinical development strategy.”
 
Tergus’ core expertise will remain focused in topical dosage forms, including creams, ointments, lotions, liquids, suspensions, gels, hydrogels, pastes, pump sprays, topical aerosols, foams, microencapsulation, liposomes, suppositories and nail lacquers.
 
Tergus co-founder and chief executive officer, Dr. Vijendra Nalamothu, has 18 years of topical drug product development and commercialization experience. Most recently he served as head of dermatology R&D for Promius Pharma and Dr. Reddy’s Laboratories. Dr. Kailas Thakker, Tergus co-founder and president, has been providing analytical services to the pharmaceutical industry with an emphasis on In Vitro Release Testing (IVRT), functional testing for semisolids and topical products, since 1994.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters